Larimar Therapeutics Inc
(LRMR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,731 | 40,777 | 19,193 | 31,726 | 28,632 |
| Marketable Securities | 43,339 | 61,275 | 73,987 | 74,266 | 88,304 |
| Receivables | 932 | 946 | 469 | 368 | 368 |
| TOTAL | $91,422 | $104,925 | $95,656 | $107,965 | $118,682 |
| Non-Current Assets | |||||
| PPE Net | 479 | 528 | 551 | 588 | 630 |
| Other Non-Current Assets | 713 | 57 | 57 | 292 | 59 |
| TOTAL | $1,192 | $585 | $608 | $880 | $689 |
| Total Assets | $92,614 | $105,510 | $96,264 | $108,845 | $119,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,796 | 3,020 | 2,676 | 4,447 | 1,910 |
| Accrued Expenses | 3,661 | 4,273 | 3,090 | 2,709 | 3,850 |
| TOTAL | $7,457 | $7,293 | $7,034 | $9,219 | $8,597 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,160 | 20,000 | N/A | N/A | N/A |
| TOTAL | $20,160 | $20,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $27,617 | $27,293 | $7,034 | $9,219 | $8,597 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,296 | 2,296 | 2,290 | 2,289 | 2,280 |
| Common Shares | 28 | 27 | 27 | 27 | 27 |
| Retained earnings | -305,533 | -289,577 | -276,492 | -263,907 | -250,560 |
| Other shareholders' equity | -49 | -58 | -28 | -41 | -63 |
| TOTAL | $64,997 | $78,217 | $89,230 | $99,626 | $110,774 |
| Total Liabilities And Equity | $92,614 | $105,510 | $96,264 | $108,845 | $119,371 |